SBI2 2025

InSphero at SBI2 2025!

Don’t miss us at SBI2 2025 in Boston, Massachusetts! This leading conference in high content imaging and informatics will enhance our understanding on how apply these technologies in new way that drive drug discovery. 

Join us and the Society for Biomolecular Imaging and Informatics as we take a closer look at advancing technological innovations and complex 3D models. SBI2 2025 is taking place from Monday, October 27th to Wednesday, October 29th.  

Meet our Team at SBI2 2025

Judi Wardwell-Swanson

Senior Scientist Consultant

Özlem Yavas Grining, PhD

Senior Scientist, Technologies and Platforms

Tamara Häfeli

Senior Research Associate, Technologies and Platforms

Thomas Hofstetter

Associate Scientist, Model Innovation and Commercialization

Poster at SBI2 2025

Multiparametric assays in 3D human liver microtissues: towards multiplexed in vitro NAMs for drug-induced liver injury (DILI) assessment​

Date: Tuesday, October 28th from 4:45 – 7:30 pm  

Poster number: #23

Tamara Häfeli

Senior Research Associate, Technologies and Platforms

Scientific Talk at SBI2 2025

Session 3: Technological Innovations in Screening

Machine learning-based, label-free detection of anti-fibrotic effects in a 3D retinal fibrosis model using bright-field imaging

Date: Wednesday, October 29th from 10:45 – 11:15 am 

Location: Atlantic Ballroom 

Thomas Hofstetter

Associate Scientist, Model Innovation and Commercialization

Lunch & Learn SBI2 2025

InSphero and Zeiss Lunch & Learn​

From Microtissues to Insights: Enhancing Drug Discovery with InSphero and ZEISS

Date: Wednesday, October 29th from 12:45 – 1:45 pm 

Location: Salon F 

Özlem Yavas Grining, PhD

Senior Scientist, Technologies and Platforms

SBI2 2025 Resources

Studying Fibrosis using 3D InSight Human MASH Microtissues Leveraging ZEISS Lattice Lightsheet 7 for 3D High-Content Analysis
Scalable Whole-Plate Calcium Imaging of Human iPSC-Derived Neural Spheroids for Drug Screening and Neurotoxicity Assessment
Non-Destructive Multiplexed Imaging of 3D Liver Microtissues for Multi-Modal DILI Assessment
Gri3D® Hydrogel Microcavity Plates
Gri3D® One Platform – Endless Possibilities
Selection Guide Akura™/Gri3D®
Multiparameter-based assays in 3D human liver microtissues: Towards multiplexed in vitro NAMs for drug-induced liver injury (DILI) assessment
Machine learning-based, label-free detection of anti-fibrotic effects in a 3D retinal fibrosis model using bright-field imaging
Scroll to Top

Your Success is Our Mission - Get in Touch

Fill in form below to contact our 3D in vitro experts

Sign up for our Newsletter

Get the latest news on 3D in vitro research

Webinar registration

Fill in the form below to register

View resource

Fill in the form below to view this resource